Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early intravenous esmolol in acute anterior wall myocardial infarction
ChiCTR2300077608Phase 4Recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Jul 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esmolol in myocardial infarction (MI) (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoints: Sudden cardiac death, Malignant ventricular arrhythmias and 1 more. Started Jul 2022; status: recruiting.
02
Drugs
esmolol
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR2300077608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077608.